Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

  • Suzanne L. Topalian
    Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg–Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
  • F. Stephen Hodi
    Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Julie R. Brahmer
    Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg–Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
  • Scott N. Gettinger
    Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut
  • David C. Smith
    Department of Internal Medicine, University of Michigan, Ann Arbor
  • David F. McDermott
    Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts
  • John D. Powderly
    Carolina BioOncology Institute, Huntersville, North Carolina
  • Jeffrey A. Sosman
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
  • Michael B. Atkins
    Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts
  • Philip D. Leming
    The Christ Hospital Cancer Center, Cincinnati, Ohio
  • David R. Spigel
    Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee
  • Scott J. Antonia
    Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
  • Alexander Drilon
    Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York
  • Jedd D. Wolchok
    Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York
  • Richard D. Carvajal
    Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York
  • M. Brent McHenry
    Bristol-Myers Squibb, Princeton, New Jersey
  • Fareeda Hosein
    Bristol-Myers Squibb, Princeton, New Jersey
  • Christopher T. Harbison
    Bristol-Myers Squibb, Princeton, New Jersey
  • Joseph F. Grosso
    Bristol-Myers Squibb, Princeton, New Jersey
  • Mario Sznol
    Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut

収録刊行物

  • JAMA Oncology

    JAMA Oncology 5 (10), 1411-, 2019-10-01

    American Medical Association (AMA)

被引用文献 (5)*注記

もっと見る

問題の指摘

ページトップへ